Research ArticleOriginal Article
Open Access

Disease phenotype and diagnostic delay in Saudi patients with primary Sjögren’s syndrome

An exploratory cross-sectional study

Mohammed A. Omair, Bashaer S. AlQahtani, Esam H. AlHamad, Yusra A. Tashkandy, Nashwa S. Othman, Khalid A. AlShahrani, Muthurajan P. Paramasivam, Fahidah AlEnzi, Rabih Halwani and Maha H. Daghestani
Saudi Medical Journal April 2021, 42 (4) 405-410; DOI: https://doi.org/10.15537/smj.2021.42.4.20200767

References

  1. 1.↵
    1. Vivino FB,
    2. Bunya VY,
    3. Massaro-Giordano G,
    4. Johr CR,
    5. Giattino SL,
    6. Schorpion A, et al.
    Sjogren’s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol 2019; 203: 81-121.
    OpenUrlCrossRef
  2. 2.
    1. Vivino FB.
    Sjogren’s syndrome: Clinical aspects. Clin Immunol 2017; 182: 48-54.
    OpenUrl
  3. 3.↵
    1. Ter Borg EJ,
    2. Kelder JC.
    Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjogren’s syndrome : A long-term study of the Antonius Nieuwegein Sjogren (ANS) cohort. Rheumatol Int 2017; 37: 1153-1158.
    OpenUrl
  4. 4.↵
    1. Perzynska-Mazan J,
    2. Maslinska M,
    3. Gasik R.
    Neurological manifestations of primary Sjogren’s syndrome. Reumatologia 2018; 56: 99-105.
    OpenUrl
  5. 5.↵
    1. Morreale M,
    2. Marchione P,
    3. Giacomini P,
    4. Pontecorvo S,
    5. Marianetti M,
    6. Vento C, et al.
    Neurological involvement in primary Sjogren syndrome: a focus on central nervous system. PLoS One 2014; 9: e84605.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Acar-Denizli N,
    2. Kostov B,
    3. Ramos-Casals M,
    4. Sjogren Big Data C.
    The Big Data Sjogren Consortium: a project for a new data science era. Clin Exp Rheumatol 2019; 37 Suppl 118: 19-23.
    OpenUrl
  7. 7.↵
    1. Brito-Zeron P,
    2. Acar-Denizli N,
    3. Ng WF,
    4. Horvath IF,
    5. Rasmussen A,
    6. Seror R, et al.
    Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjogren’s syndrome. Rheumatology (Oxford) 2020; 59: 2350-2359.
    OpenUrl
  8. 8.↵
    1. Shiboski CH,
    2. Shiboski SC,
    3. Seror R,
    4. Criswell LA,
    5. Labetoulle M,
    6. Lietman TM, et al.
    2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 2017; 76: 9-16.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Seror R,
    2. Bootsma H,
    3. Saraux A,
    4. Bowman SJ,
    5. Theander E,
    6. Brun JG, et al.
    Defining disease activity states and clinically meaningful improvement in primary Sjogren’s syndrome with EULAR primary Sjogren’s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 2016; 75: 382-389.
    OpenUrlAbstract/FREE Full Text
  10. 10.
    1. Seror R,
    2. Bowman SJ,
    3. Brito-Zeron P,
    4. Theander E,
    5. Bootsma H,
    6. Tzioufas A, et al.
    EULAR Sjogren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open 2015; 1: e000022.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Seror R,
    2. Theander E,
    3. Brun JG,
    4. Ramos-Casals M,
    5. Valim V,
    6. Dorner T, et al.
    Validation of EULAR primary Sjogren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 2015; 74: 859-866.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. AlEnzi F,
    2. Alqahtani B,
    3. Alhamad EH,
    4. Daghestani M,
    5. Tashkandy Y,
    6. Othman N, et al.
    Fatigue in Saudi patients with primary Sjogren’s syndrome and its correlation with disease characteristics and outcome measures: A cross-sectional study. Open Access Rheumatol 2020; 12: 303-308.
    OpenUrl
  13. 13.↵
    1. von Elm E,
    2. Altman DG,
    3. Egger M,
    4. Pocock SJ,
    5. Gotzsche PC,
    6. Vandenbroucke JP, et al.
    The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-349.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Brito-Zeron P,
    2. Acar-Denizli N,
    3. Zeher M,
    4. Rasmussen A,
    5. Seror R,
    6. Theander E, et al.
    Influence of geolocation and ethnicity on the phenotypic expression of primary Sjogren’s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjogren Project Consortium. Ann Rheum Dis 2017; 76: 1042-1050.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Brito-Zeron P,
    2. Acar-Denizli N,
    3. Ng WF,
    4. Zeher M,
    5. Rasmussen A,
    6. Mandl T, et al.
    How immunological profile drives clinical phenotype of primary Sjogren’s syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project). Clin Exp Rheumatol 2018; 36 Suppl 112: 102-112.
    OpenUrl
  16. 16.↵
    1. Al Arfaj AS,
    2. Khalil N.
    Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 2009; 18: 465-473.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Al Arfaj AS,
    2. Khalil N,
    3. Al Saleh S.
    Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia. Rheumatol Int 2009; 29: 1057-1067.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Omair MA,
    2. AlDuraibi FK,
    3. Bedaiwi MK,
    4. Abdulaziz S,
    5. Husain W,
    6. El Dessougi M, et al.
    Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia. Clin Rheumatol 2017; 36: 1537-1543.
    OpenUrl
  19. 19.↵
    1. Martel C,
    2. Gondran G,
    3. Launay D,
    4. Lalloue F,
    5. Palat S,
    6. Lambert M, et al.
    Active immunological profile is associated with systemic Sjogren’s syndrome. J Clin Immunol 2011; 31: 840-847.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Segal B,
    2. Thomas W,
    3. Rogers T,
    4. Leon JM,
    5. Hughes P,
    6. Patel D, et al.
    Prevalence, severity, and predictors of fatigue in subjects with primary Sjogren’s syndrome. Arthritis Rheum 2008; 59: 1780-1787.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Kuryata O
    , LysunetsI T, Karavanska I, Semenov V. Duration till diagnosis and clinical profile of Sjögren’s syndrome: Data from real clinical practice in a single-center cohort. The Egyptian Rheumatologist 2020; 42: 41-46.
    OpenUrl
  22. 22.↵
    1. Kassan SS,
    2. Moutsopoulos HM.
    Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 2004; 164: 1275-1284.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords